Cedrus LLC Merck & Co., Inc. Transaction History

Cedrus LLC

$270 Billion
Q3 2024

A detailed history of Cedrus LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cedrus LLC holds 1,869 shares of MRK stock, worth $190,395. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,869

Previous 2,901 35.57%

Holding current value

$190,395

Previous $359 Million 40.9%

% of portfolio

0.08%

Previous 0.18%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$111.15 - $128.97 $114,706 - $133,097	-1,032 Reduced 35.57%	1,869 $212 Million
Q2 2024 Jul 24, 2024	BUY	$123.8 - $132.96 $42,958 - $46,137	347 Added 13.59%	2,901 $359 Million
Q1 2024 Apr 15, 2024	SELL	$113.24 - $131.95 $93,309 - $108,726	-824 Reduced 24.39%	2,554 $337 Million
Q4 2023 Jan 26, 2024	SELL	$100.18 - $109.02 $96,272 - $104,768	-961 Reduced 22.15%	3,378 $368 Million
Q3 2023 Jan 24, 2024	BUY	$102.95 - $114.33 $32,223 - $35,785	313 Added 7.77%	4,339 $447 Million
Q2 2023 Jan 24, 2024	SELL	$108.61 - $118.38 $51,698 - $56,348	-476 Reduced 10.57%	4,026 $465 Million
Q1 2023 Jan 24, 2024	SELL	$102.94 - $114.86 $27,690 - $30,897	-269 Reduced 5.64%	4,502 $479 Million
Q4 2022 Jan 19, 2024	BUY	$87.44 - $112.11 $67,678 - $86,773	774 Added 19.36%	4,771 $529 Million
Q3 2022 Jan 19, 2024	BUY	$84.53 - $94.96 $24,767 - $27,823	293 Added 7.91%	3,997 $344 Million
Q2 2022 Jan 19, 2024	BUY	$83.49 - $94.64 $29,221 - $33,124	350 Added 10.44%	3,704 $338 Million
Q1 2022 Jan 19, 2024	BUY	$73.51 - $82.4 $17,715 - $19,858	241 Added 7.74%	3,354 $275 Million
Q4 2021 Jan 19, 2024	BUY	$72.28 - $90.54 $225,007 - $281,851	3,113 New	3,113 $239 Million

Others Institutions Holding MRK

# of Institutions

3,805

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedrus LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedrus LLC with notifications on news.

Account